In Expansion: Melanoma, Non-small Cell Lung Cancer
1 clinical trials · Condition
◉ Watch In Expansion: Melanoma, Non-small Cell Lung Cancer
| Record | Firm | Date |
|---|---|---|
| A Phase I/Ib Study of NIZ985 Alone and in Combination With Spartalizumab (NCT04261439) | Novartis Pharmaceuticals | 2020-02-27 |
Track In Expansion: Melanoma, Non-small Cell Lung Cancer automatically
Every clearance here is in the API, with alerts when new ones post.